The Hong Kong-based healthcare company Lee's Pharmaceutical Holdings (Leespharm) has acquired an exclusive licence for the marketing and sale of Recordati 's antihypertensive Zanidip (lercanidipine) in China.
The once-daily calcium antagonist was ...
Ipsen has granted Rhythm Pharmaceuticals an exclusive worldwide licence for the development and commercialisation of its melanocortin and ghrelin programmes.
The early preclinical peptide compounds in the programmes target obesity, metabolic ...
Ipsen has granted Rhythm Pharmaceuticals an exclusive worldwide licence for the development and commercialisation of its melanocortin and ghrelin programmes.
The early preclinical peptide compounds in the programmes target obesity, metabolic ...
The plenary session at the Drug Information Association’s Euromeeting in Monaco this week took the curious form of an enforced debate on pharmaceutical R&D productivity between representatives from the industry and regulatory authorities.
The motion ...
Cellzome has entered a strategic alliance with GlaxoSmithKline giving the big pharma company exclusive access to its epigenetics-based platform Episphere for drug discovery in the field of immuno-inflammatory disease.
The financial terms include an ...
